Literature DB >> 4001838

Platelet aggregation and release of ATP in patients with hepatic cirrhosis.

S Ingeberg, P Jacobsen, E Fischer, K D Bentsen.   

Abstract

The purpose of this study was to assess the platelet aggregation and releasable platelet ATP in patients with alcoholic cirrhosis (n = 10) and primary biliary cirrhosis (n = 10). In patients with liver disease a significant decrease was found in both adenosine diphosphate-induced aggregation (P less than 0.01) and collagen-induced aggregation (P less than 0.001) compared with that of controls, but there was no significant difference between the two groups of patients. Patients with primary biliary cirrhosis release smaller amounts of ATP than patients with alcoholic cirrhosis, and compared with the controls there was a significant (P less than 0.001) decrease in the releasable ATP in the patient groups. These results suggest that platelets are damaged during an intravascular activation (loss of granules), which gives rise to their subsequent hypo-function when tested in vitro.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4001838     DOI: 10.3109/00365528509091651

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  3 in total

1.  Increased soluble GPVI levels in cirrhosis: evidence for early in vivo platelet activation.

Authors:  Karl Egan; Audrey Dillon; Eimear Dunne; Barry Kevane; Zita Galvin; Patricia Maguire; Dermot Kenny; Stephen Stewart; Fionnuala Ni Ainle
Journal:  J Thromb Thrombolysis       Date:  2017-01       Impact factor: 2.300

2.  Literature-based Resurrection of Neglected Medical Discoveries.

Authors:  Don R Swanson
Journal:  J Biomed Discov Collab       Date:  2011-04-20

3.  Post-Resection Exhaustion of Intra-Platelet Serotonin: Also an Indicator of Early Hepatocellular Carcinoma Recurrence?

Authors:  Bibek Aryal; Toshiaki Shimizu; Jun Kadono; Akira Furoi; Teruo Komokata; Iwao Kitazono; Chihaya Koriyama; Munekazu Yamakuchi; Teruto Hashiguchi; Yutaka Imoto
Journal:  J Cancer       Date:  2017-10-23       Impact factor: 4.207

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.